Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9+ tumors.
Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P, Muñoz-Calleja C, Toribio ML, Kremer L, Garcia-Sanz JA. Santamaria S, et al. Among authors: castellano e. Front Immunol. 2022 Jul 27;13:825635. doi: 10.3389/fimmu.2022.825635. eCollection 2022. Front Immunol. 2022. PMID: 35967322 Free PMC article.
Overcoming tumor resistance mechanisms in CAR-NK cell therapy.
Valeri A, García-Ortiz A, Castellano E, Córdoba L, Maroto-Martín E, Encinas J, Leivas A, Río P, Martínez-López J. Valeri A, et al. Among authors: castellano e. Front Immunol. 2022 Aug 3;13:953849. doi: 10.3389/fimmu.2022.953849. eCollection 2022. Front Immunol. 2022. PMID: 35990652 Free PMC article. Review.
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.
Castellano E, Samba C, Esteso G, Simpson L, Vendrame E, García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Linares A, Leibar A, Ranganath T, Reyburn HT, Martínez-Piñeiro L, Blish C, Valés-Gómez M. Castellano E, et al. Front Immunol. 2022 Sep 15;13:970931. doi: 10.3389/fimmu.2022.970931. eCollection 2022. Front Immunol. 2022. PMID: 36189320 Free PMC article.
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.
Blasco MT, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga CG, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, Perales-Patón J, Bousquet-Mur E, Castellano E, Jacob HKC, Cabras L, Musteanu M, Drosten M, Ortega S, Mulero F, Sainz B Jr, Dusetti N, Iovanna J, Sánchez-Bueno F, Hidalgo M, Khiabanian H, Rabadán R, Al-Shahrour F, Guerra C, Barbacid M. Blasco MT, et al. Among authors: castellano e. Cancer Cell. 2019 Apr 15;35(4):573-587.e6. doi: 10.1016/j.ccell.2019.03.002. Epub 2019 Apr 8. Cancer Cell. 2019. PMID: 30975481 Free PMC article.
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression.
García-Ortiz A, Rodríguez-García Y, Encinas J, Maroto-Martín E, Castellano E, Teixidó J, Martínez-López J. García-Ortiz A, et al. Among authors: castellano e. Cancers (Basel). 2021 Jan 9;13(2):217. doi: 10.3390/cancers13020217. Cancers (Basel). 2021. PMID: 33435306 Free PMC article. Review.
BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.
Ashiru O, Esteso G, García-Cuesta EM, Castellano E, Samba C, Escudero-López E, López-Cobo S, Álvarez-Maestro M, Linares A, Ho MM, Leibar A, Martínez-Piñeiro L, Valés-Gómez M. Ashiru O, et al. Among authors: castellano e. Cancers (Basel). 2019 Jul 4;11(7):940. doi: 10.3390/cancers11070940. Cancers (Basel). 2019. PMID: 31277459 Free PMC article.
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.
Vescini F, Borretta G, Chiodini I, Boniardi M, Carotti M, Castellano E, Cipriani C, Eller-Vainicher C, Giannini S, Iacobone M, Salcuni AS, Saponaro F, Spiezia S, Versari A, Zavatta G, Mitrova Z, Saulle R, Vecchi S, Antonini D, Basile M, Giovanazzi A, Paoletta A, Papini E, Persichetti A, Samperi I, Scoppola A, Novizio R, Calò PG, Cetani F, Cianferotti L, Corbetta S, De Rimini ML, Falchetti A, Iannetti G, Laureti S, Lombardi CP, Madeo B, Marcocci C, Mazzaferro S, Miele V, Minisola S, Palermo A, Pepe J, Scillitani A, Tonzar L, Grimaldi F, Cozzi R, Attanasio R. Vescini F, et al. Among authors: castellano e. Endocr Metab Immune Disord Drug Targets. 2023 Dec 23:e141223224531. doi: 10.2174/0118715303260423231122111705. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 38644730
215 results